FibroGen Inc
NASDAQ:FGEN

Watchlist Manager
FibroGen Inc Logo
FibroGen Inc
NASDAQ:FGEN
Watchlist
Price: 8.42 USD 2.06% Market Closed
Market Cap: 34.1m USD

Wall Street
Price Targets

FGEN Price Targets Summary
FibroGen Inc

Wall Street analysts forecast FGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FGEN is 43.86 USD with a low forecast of 43.43 USD and a high forecast of 45.15 USD.

Lowest
Price Target
43.43 USD
416% Upside
Average
Price Target
43.86 USD
421% Upside
Highest
Price Target
45.15 USD
436% Upside
FibroGen Inc Competitors:
Price Targets
1801
Innovent Biologics Inc
17% Upside
ELIC
Elicera Therapeutics AB
34% Upside
002252
Shanghai RAAS Blood Products Co Ltd
8% Upside
XGN
Exagen Inc
119% Upside
0HS8
Caladrius Biosciences Inc
526% Upside
300896
Imeik Technology Development Co Ltd
39% Upside
AUPH
Aurinia Pharmaceuticals Inc
9% Upside
ARWR
Arrowhead Pharmaceuticals Inc
4% Downside

Revenue
Forecast

Revenue Estimate
FibroGen Inc

For the last 11 years the compound annual growth rate for FibroGen Inc's revenue is -11%. The projected CAGR for the next 3 years is -40%.

-11%
Past Growth
-40%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Operating Income
Forecast

Operating Income Estimate
FibroGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
18%
Average Beat

Net Income
Forecast

Net Income Estimate
FibroGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FGEN's stock price target?
Price Target
43.86 USD

According to Wall Street analysts, the average 1-year price target for FGEN is 43.86 USD with a low forecast of 43.43 USD and a high forecast of 45.15 USD.

What is FibroGen Inc's Revenue forecast?
Projected CAGR
-40%

For the last 11 years the compound annual growth rate for FibroGen Inc's revenue is -11%. The projected CAGR for the next 3 years is -40%.

Back to Top